Introduce: WE are established on the fundamental principles of enhancing the value and competitiveness of the business entities that it serves. We work hard with a single purpose of delivering excellent outcomes to the customers.
The company commenced operations in Zhuhai, China, in December 2009. We have solid-standing expertise in the process development, scale-up and production of a variety of generic APIs and advanced pharmaceutical intermediates. The experience of our R&D scientists, the capabilities of our chemists, the flexibility of our facilities and the competence of our analytical support enable us to provide to our customers products of a global quality.
Our goal is to develop value added products through concerted research in the fields of manufacturing process, creating and delivering innovative and quality APIs and intermediates at a highest professional level, using our modern laboratory facilities to meet the requirements of our customers. Currently, the leading products are including: Fluvoxamine maleate & its intermediates, Zonisamide and its intermediates, Ethyl ascorbic acid, Triprolidine Hydrochloride, Doxylamine Succinate, Carbinoxamine Maleate, ect. We value the excellent relationship we have established with our customers worldwide, and are looking to continuing to meet the needs of the world pharmaceutical producers.
